Showing results (251-260 of 816) with videos related to

Sort By:
Pageof 82
Critical Care Medicine|May 16, 2000
Outcome of bone marrow transplantation patients requiring mechanical ventilationA J Huaringa, F J Leyva, S A Giralt, et al.
Bone Marrow Transplantation|February 3, 2004
Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokineticsI F Khouri, M Albitar, R M Saliba, et al.
Bone Marrow Transplantation|June 11, 2003
Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancerR Wong, G Rondon, R M Saliba, et al.
Nature Medicine|September 6, 2000
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemiaJ J Molldrem, P P Lee, C Wang, et al.
Experimental Hematology|March 1, 1986
Recurrence of acute leukemia more than two years after allogeneic marrow graftingR Witherspoon, N Flournoy, E D Thomas, et al.
Transplantation|June 9, 1999
The use of an anti-TCRalphabeta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiationA A Barsoukov, P F Moore, R Storb, et al.
Bone Marrow Transplantation|November 1, 1990
Cytomegalovirus infection after marrow transplantation for aplastic anemiaP Ljungman, D Niederwieser, M S Pepe, et al.
Clinical and Experimental Immunology|June 1, 1982
Immunoglobulin production after marrow transplantation. III. The functional heterogeneity of FC-IgG receptor positive and negative T cell subpopulationsL G Lum, M C Seigneuret, N Orcutt-Thordarson, et al.
Transplantation|September 1, 1979
Effect of trimethoprim-sulfamethoxazole on hematological recovery after total body irradiation and autologous marrow infusion in dogsH J Deeg, J D Meyers, R Storb, et al.
Tissue Antigens|August 1, 1981
Increased frequency of the group 5a antigen in patients with hematologic malignanciesR P Warren, R Storb, N J Nelson, et al.
Pageof 82